Loading company…
Rainier Therapeutics, Inc. of San Leandro, US is a biopharmaceutical company developing treatments for chronic conditions.
Founded in 2010 and based in San Leandro, US, Rainier Therapeutics, Inc. develops biopharmaceutical products aimed at chronic conditions and unmet medical needs. Fusion Pharmaceuticals Inc. acquired the company in July 2021 for undisclosed terms. The company has completed 9 deals, and its latest funding round in 2021 raised USD 10.00 mn, which matches its total raised. It is at Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in